Benitec Biopharma Inc (BNTC) Return on Assets ROA from the first quarter of 2026 to first quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket
 


Benitec Biopharma Inc   (NASDAQ: BNTC)


Benitec Biopharma Inc 's ROA from the first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Benitec Biopharma Inc 's ROA in the first quarter of 2026?
Benitec Biopharma Inc recorded a cumulative net loss of $-50 million during 12 months ending in the first quarter of 2026, resulting in a negative return on assets (ROA) of -19.12%.

However, within the Healthcare sector 437 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 3733, from total ROA ranking in the fourth quarter of 2026 at 4552.

What is ROA?



Return On Assets (Sep 30 2026)
I. Quarter
(Jun 30 2026)
IV. Quarter
(Mar 31 2026)
III. Quarter
(Dec 31 2025)
II. Quarter
(Sep 30 2025)
I. Quarter
Y / Y Total Assets Change 85.88 % 295.06 % 77.83 % 90.75 % 178.06 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -50 -46 -42 -44 -42
Return On Assets (TTM) -19.12 % -20.91 % -28.78 % -35.6 % -37.33 %
BNTC's Total Ranking # 3733 # 4552 # 4031 # 4069 # 4176
Total Assets (TTM) in million 355 393 187 100 191
Seq. Total Assets Change -9.66 % 110.4 % 87.77 % -47.92 % 92.02 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 169
Sector # 438
Overall # 3666

Return On Assets Statistics
High Average Low
14.93 %
-102.33 %
-212.79 %
(Jun 30 2019)   (Jun 30 2023)





Financial Statements
Benitec Biopharma Inc 's Assets $ 355 million BNTC's Balance sheet
Benitec Biopharma Inc 's Income $ -13 million Quarterly BNTC's Income Statement
BNTC's Income by Division See BNTC's Income by Division



Annual Return On Assets (Jun 30 2026)
FY 2026
(Jun 30 2025)
FY 2025
(Jun 30 2024)
FY 2024
(Jun 30 2023)
FY 2023
(Jun 30 2022)
FY 2022
Y / Y Total Assets Change 295.06 % 90.75 % 1069.58 % -25.26 % -72.06 %
Total Assets in million 393 100 52 4 6
Y / Y Net Income Change - - - - -
Net Income in million -46 -38 -22 -20 -18
Annual Return On Assets -11.58 % -38.07 % -42.85 % -438.22 % -304.84 %




More Return On Assets Ratios
BNTC's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BNTC's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BNTC's Competitors
Subscribers only: Roa for Benitec Biopharma Inc 's Suppliers
Subscribers only: Return On Assets for BNTC's Customers

You may also want to know
BNTC's Roi BNTC's Inventory Turnover Ratio BNTC's Growth Rates BNTC's Dividend Comparisons
BNTC's Profitability Ratios BNTC's Asset Turnover Ratio BNTC's Dividend Growth
BNTC's Roe BNTC's Valuation Ratios BNTC's Financial Strength Ratios BNTC's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector ROA


Date modified: 2026-11-14T08:46:18+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.